Events & Presentations
| Date | Event Details | Remind Me |
|---|---|---|
|
Sep 26, 2023 10:30 AM EDT
|
2023 Cantor Fitzgerald Global Healthcare Conference
|
| Date | Event Details |
|---|---|
|
Nov 12 - Nov 15, 2021
|
The Liver Meeting, the Annual Meeting of the American Association for the Study of Liver Disease (AASLD)
AASLD 2021 AROAAT2002 poster 1.3 MB
AASLD 2021 AROHSD1001 poster 1.5 MB
AASLD 2021 REEF-1 Late-Breaker Oral 484.5 KB
Title: ARO-AAT Treatment Reduces Intra-hepatic Z-AAT Leading to Improved Parameters of Liver Health and Fibrosis Regression Title: ARO-HSD, An Investigational RNAi Therapeutic, Demonstrates Reduction in ALT and Hepatic HSD17B13 mRNA and Protein in Patients with NASH or Suspected NASH Title: Efficacy and Safety of the siRNA JNJ-3989 and/or the Capsid Assembly Modulator (CAM) JNJ-6379 for the Treatment of Chronic Hepatitis B Virus Infection (CHB): Results from the Phase 2B REEF-1 Study |
|
Oct 26, 2021 3:00 PM EDT
|
ARO-C3 KOL Webinar
View Presentation 3.8 MB
|
|
Oct 12, 2021 2:00 PM EDT
|
H.C. Wainwright 5th Annual NASH Investor Conference
James Hamilton, M.D., MBA, Arrowhead’s senior vice president of discovery and translational medicine will participate in a fireside chat presentation
|
|
Oct 4, 2021 4:30 PM EDT
|
Chardan's 5th Annual Genetic Medicines Conference
Vince Anzalone, CFA, Arrowhead’s vice president of investor relations, will participate in a fireside chat presentation
|
|
Sep 29, 2021 9:20 AM EDT
|
2021 Cantor Virtual Global Healthcare Conference
Chris Anzalone, Ph.D., Arrowhead’s president and CEO, will participate in a fireside chat presentation
|
|
Sep 14, 2021 4:55 PM EDT
|
Baird's 2021 Global Healthcare Conference
Vince Anzalone, CFA, Arrowhead’s vice president of investor relations, will participate in a fireside chat presentation
|
|
Sep 13, 2021 7:00 AM EDT
|
HC Wainwright 23rd Annual Global Investment Conference
Chris Anzalone, Ph.D., Arrowhead’s president and CEO, will participate in a fireside chat presentation
|
|
Sep 9, 2021
|
Citi’s 16th Annual BioPharma Virtual Conference
Arrowhead management will host a day of virtual investor meetings
|
|
Aug 5, 2021 4:30 PM EDT
|
Arrowhead Pharmaceuticals 2021 Third Quarter Results
Prepared Remarks 178.2 KB
|
|
Jun 25, 2021
|
28th Annual FSHD Society International Research Congress
View Presentation 2.3 MB
Jonathan Van Dyke, Ph.D., Arrowhead’s senior scientist II of biology, will deliver an oral presentation on the preclinical development of ARO-DUX4
|